Diabetes Prevention Program Translation in the Veterans Health Administration

Am J Prev Med. 2017 Jul;53(1):70-77. doi: 10.1016/j.amepre.2016.11.009. Epub 2017 Jan 13.

Abstract

Introduction: This clinical demonstration trial compared the effectiveness of the Veterans Affairs Diabetes Prevention Program (VA-DPP) with an evidence-based usual care weight management program (MOVE!®) in the Veterans Health Administration health system.

Design: Prospective, pragmatic, non-randomized comparative effectiveness study of two behavioral weight management interventions.

Setting/participants: Obese/overweight Veterans with prediabetes were recruited from three geographically diverse VA sites between 2012 and 2014.

Intervention: VA-DPP included 22 group-based intensive lifestyle change sessions.

Main outcome measures: Weight change at 6 and 12 months, hemoglobin A1c (HbA1c) at 12 months, and VA health expenditure changes at 15 months were assessed using VA electronic health record and claims data. Between- and within-group comparisons for weight and HbA1c were done using linear mixed-effects models controlling for age, gender, race/ethnicity, baseline outcome values, and site. Analyses were conducted in 2015-2016.

Results: A total of 387 participants enrolled (273 VA-DPP, 114 MOVE!). More VA-DPP participants completed at least one (73.3% VA-DPP vs 57.5% MOVE! p=0.002); four (57.5% VA-DPP vs 42.5% MOVE!, p=0.007); and eight or more sessions (42.5% VA-DPP vs 31% MOVE!, p=0.035). Weight loss from baseline was significant at both 6 (p<0.001) and 12 months (p<0.001) for VA-DPP participants, but only significant at 6 months for MOVE! participants (p=0.004). Between groups, there were significant differences in 6-month weight loss (-4.1 kg VA-DPP vs -1.9 kg MOVE!, p<0.001), but not 12-month weight loss (-3.4 kg VA-DPP vs -2.0 kg MOVE!, p=0.16). There were no significant differences in HbA1c change or outpatient, inpatient, and total VA expenditures.

Conclusions: VA-DPP participants had higher participation rates and weight loss at 6 months, but similar weight, HbA1c, and health expenditures at 12 months compared to MOVE!

Participants: Features of VA-DPP may help enhance the capability of MOVE! to reach a larger proportion of the served population and promote individual-level weight maintenance.

Publication types

  • Comparative Study
  • Pragmatic Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Behavior Therapy / methods*
  • Body Weight
  • Diabetes Mellitus, Type 2 / prevention & control*
  • Disease Progression
  • Electronic Health Records / statistics & numerical data
  • Evidence-Based Medicine / methods
  • Exercise / physiology
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Life Style
  • Male
  • Middle Aged
  • Obesity / blood
  • Obesity / complications
  • Obesity / therapy*
  • Prediabetic State / blood
  • Prediabetic State / pathology
  • Prediabetic State / therapy*
  • Prospective Studies
  • Treatment Outcome
  • United States
  • United States Department of Veterans Affairs / statistics & numerical data
  • Veterans Health*
  • Weight Loss
  • Weight Reduction Programs / methods*

Substances

  • Glycated Hemoglobin A